Advertisement

Search Results for "Clinical Trial Nexmed 2012"

01:59 EDT 18th May 2013 | BioPortfolio

Matching Channels

ATX-MS-1467 for patients with multiple sclerosis (MS)

ATX-MS-1467 is a novel treatment that was developed with the aim of working with the immune system to treat the underlying cause of disease rather than just treating the symptoms or suppressing the...

macitentan

Macitentan (Opsumit®) is a novel dual endothelin receptor antagonist (ERA) that resulted from a tailored drug discovery process with the target to develop an ERA optimized for efficacy and safet...

Clinical Approvals - news, views, reports and blogs

Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and eff...

Vitamin E Toxicity

Research has not found any adverse effects from consuming vitamin E in food. However, high doses of alpha-tocopherol supplements can cause hemorrhage and interrupt blood coagulation in animals, and...

Contract Research Organization news

A contract research organization, also called a clinical research organization, (CRO) is a service organization that provides support to the pharmaceutical and biotechnology industries in the form o...

Matching News

Apricus Biosciences' Wholly-Owned Subsidiary NexMed (U.S.A.) and Takeda Pharmaceuticals International GmbH Sign Exclusive License Agreement to Market Vitaros(R) in the United Kingdom

SAN DIEGO and ZURICH, Switzerland, Sept. 13, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI) and Takeda Pharmaceuticals International GmbH jointly announced today that they have ente...

Research on clinical trial issues for biosimilars

Period: September to December 2012 In order to demonstrate comparability between a biosimilar and its reference product, EMA recommends that the clinical trial should make it possible to detect a...

BRIEF-Apricus Biosciences' unit and Takeda Pharmaceuticals sign license agreement

Sept 13 (Reuters) - Apricus Biosciences Inc : * Biosciences' wholly-owned subsidiary Nexmed (U.S.A.) and Takeda

ATL1103 Phase II Clinical Trial ? Start Up Activities Commence

Key appointments made ? Chief Investigator and Clinical Research Organisation Study design and clinical trial protocol finalised Dosing of patients planned to commence 4’Q’201...

EAHP discusses Clinical Trial regulation with Commission, voicing some concerns

The European Association of Hospital Pharmacists (EAHP) last week met with officials at the European Commission to share the hospital pharmacy perspective on clinical trial regulation. The meeting too...

Nextrials’s new iPad app to offer mobile access to clinical trial data and study metrics

Nextrials, a web-based software solutions company for the clinical research industry, announced that its iPad application for Prism, its award-winning clinical trial management platform, will be avai...

Biotron completes clinical stage of HIV clinical trial

Biotron Limited (BIT) has completed the clinical stage of a landmark phase 1b/2a proof-of-concept human trial of its lead HIV drug candidate, BIT225. The placebo-controlled, double-blinded study was u...

EMA Finalises Access to Clinical Trials Advice

Précis:  The European Medicines Agency (EMA) has just released its final advice resulting from the clinical trial advisory groups set up last year. T...

Matching PubMed Articles

A comparison of screening methods in two early phase oral leukoplakia clinical trials.

Oral Diseases (2012) doi: 10.1111/j.1601-0825.2012.01934.x Objectives/Introduction:  Clinical trial accrual for oral dysplasia is difficult in the United States and elsewhere. Patients with dysplast...

Individualization of Drug Therapy: History, Present State, and Opportunities for the Future.

Individualization of drug therapy, described as tailoring drug selection and drug dosing to a given patient, has been an objective of physicians and other health-care providers for centuries. An under...

Do messages of scarcity increase trial recruitment?

INTRODUCTION: Psychological theory suggests that participants may be more likely to volunteer to join a clinical trial if they perceive places in the trial are a scarce commodity. MATERIAL AND METHODS...

Empirical shrinkage estimator for consistency assessment of treatment effects in multi-regional clinical trials.

Multi-regional clinical trials have been widely used for efficient global new drug developments. Both a fixed-effect model and a random-effect model can be used for trial design and data analysis of a...

Flexible bivariate phase II clinical trial design incorporating toxicity and response on different schedules.

The single-arm, two-stage clinical trial is a popular design utilized to evaluate oncology treatments. The designs are typically augmented with an ad hoc toxicity monitoring rule that is imposed outsi...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement